HBV相关慢加急性肝衰竭患者Th17、Treg变化及其与临床相关性

肝脏 ›› 2016, Vol. 21 ›› Issue (2): 89-91.

HBV相关慢加急性肝衰竭患者Th17、Treg变化及其与临床相关性

阚延婷, 甘建和, 孙蔚, 冯婷婷

215006 江苏苏州大学附属第一医院感染科

收稿日期:2015-08-24 出版日期:2016-02-29 发布日期:2020-06-28
通讯作者: 甘建和,Email:ganjianhe@aliyun.com
基金资助:
国家“十二五”科技重大专项(2012ZX10002004-008)

Frequency of Th17 and Treg in HBV-related acute-on-chronic liver failure and its clinical value

KAN Yan-ting, GAN Jian-he, SUN Wei, FENG Ting-ting

Department of Infectious Diseases, First Affiliated Hospital of Suzhou University, Jiangsu 215006, China

Received:2015-08-24 Online:2016-02-29 Published:2020-06-28
Contact: Gan Jian-he, Email: ganjianhe@aliyun.com

摘要/Abstract

摘要： 目的研究Th17、Treg及Th17/Treg在乙型肝炎相关慢加急性肝衰竭(ACHBLF)患者外周血的变化,及其与病情进展及预后的相关性。方法选取33例ACHBLF患者,30例慢性乙型肝炎患者及11名健康对照。用流式细胞技术检测血清中Th17、Treg频数,分析ACHBLF患者Th17、Treg频数的变化及其与TBil、ALT、PT等指标的相关性。结果 ACBLF患者的Th17(1.96±0.99)%比CHB患者(0.59±0.40)%及健康对照者(0.26±0.20)%高(P<0.05);ACHBLF的Th17/Treg(0.46±0.32)比CHB患者(0.12±0.11)及健康对照者(0.07±0.06)的高(P<0.05);ACHBLF患者中,死亡者的Th17比存活者高;Th17细胞频数及Th17/Treg与PT、ALT及AST呈正相关(P<0.05),与总胆红素无显著相关性,Th17/Treg与AFP呈正相关(P<0.05)。结论 ACHBLF患者存在不同程度的免疫功能紊乱,Th17及Th17/Treg与病情进展相关,且对患者预后有重要价值,Th17越高预后越差。

关键词: Th17, Th17/Treg, ACHBLF, 病情进展, 预后

Abstract: Objective To investigate the frequency of peripheral Th17, Treg and Th17/Treg in patients with hepatitis B-related acute-on-chronic liver failure (HBV-ACLF), and its correlation with disease progression and prognosis. Methods Seventy-four cases were enrolled, including 33 HBV-ACLF cases (HBV-ACLF group), 30 chronic hepatitis B cases (CHB group) and 11 healthy cases (control group). The frequency of Th17 and Treg cells and surface antigen quantity in peripheral blood were detected in three groups with flow cytometry technique, respectively. Correlation analysis between changes of Th17 and Treg frequency in the HBV-related ACLF cases and total bilirubin (TBiL), alanine aminotransferase (ALT) and prothrombin time (PT) was performed. Results Frequency of Th17, Treg cells and proportion of Th17/Treg were higher in HBV-ACLF patients than those in CHB and control group (P<0.05), respectively. In HBV-ACLF group, frequency of Th17 in dead patients were higher than that in survivors; frequency of Th17 and Th17/Treg were positively correlated with PT, ALT and AST (P<0.05) with no significant correlation with TBiL. Additionally, Th17/Treg was also positively correlated with alpha fetoprotein (AFP) (P<0.05). Conclusion There were different degrees of immune dysfunction in HBV-ACLF patients. Frequency of Th17 and Th17/Treg were associated with disease progression. Higher frequency of Th17 predicted worse prognosis, which revealed it might be important indicators for those patients.

Key words: Th17, Th17/Treg, ACHBLF, Disease progression, Prognosis

阚延婷, 甘建和, 孙蔚, 冯婷婷. HBV相关慢加急性肝衰竭患者Th17、Treg变化及其与临床相关性[J]. 肝脏, 2016, 21(2): 89-91.

KAN Yan-ting, GAN Jian-he, SUN Wei, FENG Ting-ting. Frequency of Th17 and Treg in HBV-related acute-on-chronic liver failure and its clinical value[J]. Chinese Hepatolgy, 2016, 21(2): 89-91.

参考文献

1 Lok AS.The maze of treatments for hepatitis B. N Engl J Med, 2005, 352:2743-2746.
2 Sarin SK, Kumar A, Almeida JA, et al.Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int, 2009,3:269-282.
3 邹正升,陈菊梅,辛绍杰,等. 慢性重型病毒性肝炎发病特点的探讨. 中华实验和临床病毒学杂志,2002,16: 322-325.
4 Sen S, Davies NA, Mookerjee RP, et al.Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl, 2004,10:1109-1119.
5 Franzese O, Kennedy PT, Gehring AJ, et al.Modulation of the CD8+-T-cell response by CD4+CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol, 2005,79:3322-3328.
6 Xu D, Fu J, Jin L, et al.Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the anti-viral immune response and disease progression in patients with hepatitis B. J Immunol, 2006,177:739-747.
7 Zhou L, Lopes JE, Chong MM, et al.TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature, 2008,453: 236-240.
8 Kimura A, Kishimoto T.IL-6: regulator of Treg/Th17 balance. Eur J Immunol, 2010,40: 1830-1835.
9 Lemmers A, Moreno C, Gustot T,et al.The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology, 2009,49:646-657.
10 Su ZJ, Yu XP, Guo RY, et al.Changes in the balance between Treg and Th17 cells in patients with chronic hepatitis B.Diagn Microbiol Infect Dis, 2013,76:437-444.
11 Li J, Wang L, Wang S, et al.The Treg/Th17 imbalance in patients with idiopathic dilated cardiomyopathy. Scand J Immunol, 2010,71: 298-303.
12 Liang XS, Li CZ, Zhou Y, et al.Changes in circulating Foxp3(+) regulatory T cells and interleukin-17-producing T helper cells during HBV-related acute-on-chronic liver failure.World J Gastroenterol, 2014, 20: 8558-8571.
13 Niu YH, Yin DL, Liu HL, et al.Restoring the Treg cell to Th17 cell ratio may alleviate HBV-related acute-on-chronic liverfailure.World J Gastroenterol, 2013, 19: 4146-4154.
14 Zhang GL, Xie DY, Lin BL, et al.Imbalance of interleukin-17-producing CD4 T cells/regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acute-on-chronic liver failure. J Gastroenterol Hepatol, 2013, 28:513-521.
15 Zhang JY, Zhang Z, Lin F, et al.Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology, 2010,51: 81-91.
16 Wang LY,Meng QH,Zou ZQ, et al.Increased frequency of circulating Th17 cells in acute-on-chronic hepatitis B liver failure. Dig Dis Sci, 2012, 57:667-674.

[1]	王敏. 肝癌患者自发性破裂出血的影响因素及预后因素分析[J]. 肝脏, 2020, 25(5): 510-513.
[2]	刘栋, 苏康乐, 张翠杰, 翟亚玲, 李芳华. 肾小管HBAg阳性表达与HBV相关肾功能损伤预后的关系[J]. 肝脏, 2020, 25(4): 372-374.
[3]	高朋彬, 郑欢伟, 赵晓彦, 王德华, 秦浩, 孟明辉, 张建集, 闫双缓. 内科综合治疗HBV-ACLF患者的临床特点及转归[J]. 肝脏, 2020, 25(4): 375-378.
[4]	赵梦, 陈明, 王丽, 胡孙裔. 自身免疫性肝炎患儿临床特点与预后[J]. 肝脏, 2020, 25(4): 379-381.
[5]	曾丹, 王卫政. Th17和Treg细胞在慢加急性乙型肝炎肝衰竭患者外周血中的表达及临床价值[J]. 肝脏, 2020, 25(4): 419-422.
[6]	王雨, 许达峰, 周开伦, 武金才, 丁驿超, 古海强, 谢明微, 林明花. TLR4和肠道菌群在原发性肝癌进展中动态变化及与预后的关系[J]. 肝脏, 2020, 25(3): 273-276.
[7]	余守江, 王国兴, 马兰芳. TACE联合微波消融对原发性肝癌患者肿瘤组织灌注、免疫功能及预后的影响[J]. 肝脏, 2020, 25(3): 294-296.
[8]	李亚飞, 闫华楠, 韩少静, 郭永泽, 韩书香, 李淑霞, 吉丽, 张宏伟. 老年急性药物性肝损伤临床特征及预后影响因素分析[J]. 肝脏, 2020, 25(3): 319-322.
[9]	黄菁, 张永臣, 虞玲. 外周血Th17相关炎性因子在慢性乙型肝炎患者接受Peg-IFNα治疗前后的变化及临床意义[J]. 肝脏, 2020, 25(2): 194-196.
[10]	原庆会, 何伟. Vimentin在肝细胞癌组织中的表达及其与临床预后的关系[J]. 肝脏, 2020, 25(2): 199-201.
[11]	刘莉, 吕蓉蓉, 陈光耀, 邹佳丽, 盛佳琪. 35例小儿肝功能衰竭PE联合CVVHDF技术治疗的疗效及预后分析[J]. 肝脏, 2019, 24(9): 1028-1031.
[12]	姚本来, 李晓明, 李芳飘, 姚立鹏. Treg和IL-10在肝癌组织的表达及评估预后的价值[J]. 肝脏, 2019, 24(8): 921-922.
[13]	黎李萍, 伍民生, 唐艳芳, 刘品晶, 陈盛奎. 重症病毒性肝炎患者医院感染病原菌特征及其与预后的关系[J]. 肝脏, 2019, 24(8): 923-924.
[14]	李瑞, 周长东. ERCP术后行LC手术时机的选择对胆囊合并胆总管结石患者肝功能、炎性反应及预后的影响[J]. 肝脏, 2019, 24(8): 938-940.
[15]	贾铭丽, 汪云. 血清淀粉样蛋白A联合腺苷脱氨酶在自身免疫性肝炎的价值分析[J]. 肝脏, 2019, 24(7): 773-776.